Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Kayleigh Russell
CONTACT
Mark Nelson
CONTACT
Lead
ImmunityBio, Inc.
This is an open label, phase 1b single arm trial with a safety lead-in cohort to determine the preliminary efficacy and safety of EV plus pembrolizumab and NAI in participants with unresectable locally advanced or mUC who are treatment-naïve in the metastatic setting.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted